Temperature excursion (revision 3)
Old revision·15:01, 19 Apr 2025·ShortDescShai
| Temperature excursion | |
|---|---|
| Definition | Deviation outside labelled storage conditions |
| Assessed by | Duration, magnitude and cumulative exposure |
| Summary statistic | Mean kinetic temperature |
| Disposition outcomes | Release, shortened dating, or rejection |
| Topic infobox · conventions | |
A temperature excursion is an episode in which a product is held outside the storage conditions stated on its label. The term is used in pharmaceutical distribution and manufacturing for a deviation whose consequences must be assessed before the product is released for further use, and the assessment is a documented judgement about degradation rather than a rule about temperature.[1]
An excursion is defined relative to a label, not to an absolute temperature. Because compendial definitions of controlled cold and controlled room temperature build permitted excursion bands into the definitions themselves, a departure from the nominal range is not automatically an excursion in the regulatory sense; a product labelled for storage at 2–8 °C that reaches 15 °C for an hour may remain within its labelled conditions, whereas the same profile applied to a product labelled for frozen storage would not.[2]
Definition and framing
[edit]Distribution and compendial guidance treat an excursion as a deviation requiring investigation. The European good distribution practice guidelines require that deviations be recorded and their effect on quality evaluated, and that product not be released for further distribution until that evaluation is complete. WHO model guidance takes the same approach and adds the concept of a stability budget: the total permitted exposure outside labelled conditions, allocated across the product's life, against which each event is charged.[3][4]
Three framings of the same event coexist and are worth distinguishing.
- The compliance framing
- Did the product leave its labelled conditions? This is answered by comparing a record against a label, and is a question about documents.
- The kinetic framing
- How much additional degradation is expected? This is answered by applying a rate model to the exposure, and is a question about chemistry.
- The analytical framing
- Can any change be measured? This is answered by testing, and is a question about method capability.
References
- ^ United States Pharmacopeia, General Chapter <1079>, "Risks and Mitigation Strategies for the Storage and Transportation of Finished Drug Products" (informational). USP–NF, current revision.
- ^ United States Pharmacopeia, General Chapter <659>, "Packaging and Storage Requirements". USP–NF, current revision.
- ^ European Commission. Guidelines of 5 November 2013 on Good Distribution Practice of medicinal products for human use (2013/C 343/01).
- ^ World Health Organization. "Model guidance for the storage and transport of time- and temperature-sensitive pharmaceutical products." WHO Technical Report Series No. 961, Annex 9 (2011).